Edit |   |
---|---|
Antigenic Specificity | Influenza A Virus Hemagglutinin HA (Gedivumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Gedivumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Influenza A Virus Hemagglutinin HA, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Gedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers). |
Immunogen | n/a |
Other Names | Gedivumab, Influenza A Virus Hemagglutinin HA, 1807954-17-1 |
Gene, Accession # | CAS: 1807954-17-1 |
Catalog # | abx831421 |
Price | please inquire |
Order / More Info | Influenza A Virus Hemagglutinin HA (Gedivumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950